Im vergangenen Jahr erzielte Utah Medical Products Inc für sein leistungsstärkstes Segment, Gynecology/Electrosurgery/Urology, Einnahmen von 19.72M USD. Die Region United States leistete den größten Beitrag mit 22.76M USD im letzten Jahr.

Nach Geschäftsbereich

Umsatz

Anteil

Jährlich

Jährlich

Vierteljährlich

Gynecology/Electrosurgery/Urology

Neonatal

Blood Pressure Monitoring and Accessories

Obstetrics

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

Gynecology/Electrosurgery/Urology

19.72M(51.19%)

20.71M(50.62%)

22.30M(44.40%)

21.84M(41.78%)

21.97M(44.79%)

20.55M(48.73%)

25.35M(54.06%)

Neonatal

8.01M(20.79%)

6.87M(16.79%)

6.86M(13.66%)

7.57M(14.47%)

6.69M(13.64%)

5.87M(13.92%)

6.07M(12.93%)

Blood Pressure Monitoring and Accessories

6.79M(17.63%)

9.07M(22.17%)

16.47M(32.79%)

18.21M(34.83%)

15.71M(32.04%)

11.23M(26.63%)

10.48M(22.35%)

Obstetrics

4.00M(10.38%)

4.26M(10.41%)

4.59M(9.14%)

4.66M(8.92%)

4.67M(9.53%)

4.52M(10.72%)

5.00M(10.66%)

Nach Region

Umsatz

Anteil

Jährlich

Jährlich

Vierteljährlich

United States

Europe

Other

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

FY2015

FY2014

FY2013

FY2012

FY2011

United States

22.76M(59.09%)

23.87M(58.36%)

30.41M(60.55%)

34.52M(66.04%)

31.76M(64.74%)

25.87M(61.33%)

27.49M(58.62%)

21.19M(50.46%)

20.29M(48.98%)

19.49M(49.59%)

20.36M(50.71%)

19.48M(47.20%)

18.96M(46.84%)

19.95M(48.03%)

18.85M(49.80%)

Europe

7.93M(20.58%)

8.71M(21.28%)

8.92M(17.76%)

7.21M(13.80%)

7.43M(15.15%)

6.40M(15.17%)

8.91M(18.99%)

9.16M(21.81%)

8.52M(20.57%)

7.99M(20.33%)

7.72M(19.22%)

8.94M(21.66%)

9.08M(22.42%)

9.29M(22.35%)

7.82M(20.66%)

Other

7.83M(20.33%)

8.32M(20.35%)

10.89M(21.69%)

10.54M(20.17%)

9.86M(20.10%)

9.91M(23.50%)

10.51M(22.40%)

11.65M(27.73%)

12.61M(30.45%)

11.82M(30.08%)

12.07M(30.06%)

12.86M(31.14%)

12.45M(30.75%)

12.31M(29.63%)

11.19M(29.55%)